DTYMK
Thymidylate kinase
Also known as: CDC8, KTHY_HUMAN, TMPK, TYMK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23919
- Gene
- DTYMK
- Ensembl
- ENSG00000168393
- Chromosome
- 2
- Canonical length
- 212 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables ATP binding activity and dTMP kinase activity. Involved in dTDP biosynthetic process and thymidine biosynthetic process. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
212 residues, UniProt reviewed canonical sequence.
>P23919|DTYMK
1 MAARRGALIV LEGVDRAGKS TQSRKLVEAL CAAGHRAELL RFPERSTEIG KLLSSYLQKK
61 SDVEDHSVHL LFSANRWEQV PLIKEKLSQG VTLVVDRYAF SGVAFTGAKE NFSLDWCKQP
121 DVGLPKPDLV LFLQLQLADA AKRGAFGHER YENGAFQERA LRCFHQLMKD TTLNWKMVDA
181 SKSIEAVHED IRVLSEDAIR TATEKPLGEL WKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DTYMK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 35 nTPM
- esophagus: 24 nTPM
- lymph node: 23 nTPM
- liver: 23 nTPM
- thymus: 23 nTPM
- kidney: 21 nTPM
Single-cell type
- extravillous trophoblasts: 172 nCPM
- esophageal basal cells: 162 nCPM
- migrating cytotrophoblasts: 128 nCPM
- erythrocyte progenitors: 127 nCPM
- enteric transient amplifying cells: 108 nCPM
- hofbauer cells: 102 nCPM
Immune cell
- intermediate monocyte: 47 nTPM
- T-reg: 42 nTPM
- plasmacytoid DC: 39 nTPM
- non-classical monocyte: 37 nTPM
- naive B-cell: 37 nTPM
- memory B-cell: 36 nTPM
Brain region
- basal ganglia: 16 nTPM
- thalamus: 16 nTPM
- white matter: 16 nTPM
- medulla oblongata: 15 nTPM
- cerebral cortex: 15 nTPM
- choroid plexus: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DTYMK.
Disease | AllUniProt
Conditions DTYMK is implicated in, by any mechanism.
- Neurodegeneration, childhood-onset, with progressive microcephaly (CONPM) MIM:619847
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 58 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodegeneration, childhood-onset, with progressive microcephaly
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- -1.43
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to growth factor stimulus
- dTDP biosynthetic process
- dTTP biosynthetic process
- dUDP biosynthetic process
- thymidine biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-loop containing nucleoside triphosphate hydrolase
- Thymidylate kinase-like domain
- Thymidylate kinase
- Thymidylate kinase
- Thymidylate kinase, conserved site
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DTYMK as an antibody target. Whether an autoantibody or antibody against DTYMK could matter depends on whether native DTYMK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DTYMK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DTYMK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...